These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 15383024

  • 21. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function.
    Knutson F, Alfonso R, Dupuis K, Mayaudon V, Lin L, Corash L, Högman CF.
    Vox Sang; 2000; 78(4):209-16. PubMed ID: 10895093
    [Abstract] [Full Text] [Related]

  • 22. Photochemical inactivation of pathogenic bacteria in human platelet concentrates.
    Lin L, Londe H, Janda JM, Hanson CV, Corash L.
    Blood; 1994 May 01; 83(9):2698-706. PubMed ID: 8167348
    [Abstract] [Full Text] [Related]

  • 23. Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates.
    Bruchmüller I, Janetzko K, Bugert P, Mayaudon V, Corash L, Lin L, Klüter H.
    Transfusion; 2005 Sep 01; 45(9):1464-72. PubMed ID: 16131379
    [Abstract] [Full Text] [Related]

  • 24. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets.
    Bruchmüller I, Lösel R, Bugert P, Corash L, Lin L, Klüter H, Janetzko K.
    Platelets; 2005 Dec 01; 16(8):441-5. PubMed ID: 16287610
    [Abstract] [Full Text] [Related]

  • 25. The extent of amotosalen photodegradation during photochemical treatment of platelet components correlates with the level of pathogen inactivation.
    Liu W, Cimino GD, Corash L, Lin L.
    Transfusion; 2011 Jan 01; 51(1):52-61. PubMed ID: 20663111
    [Abstract] [Full Text] [Related]

  • 26. Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods.
    Nussbaumer W, Allerstorfer D, Grabmer C, Rheinschmidt M, Lin L, Schönitzer D, Lass-Flörl C.
    Transfusion; 2007 Jul 01; 47(7):1125-33. PubMed ID: 17581146
    [Abstract] [Full Text] [Related]

  • 27. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.
    Roback JD, Conlan M, Drew WL, Ljungman P, Nichols WG, Preiksaitis JK.
    Transfus Med Rev; 2006 Jan 01; 20(1):45-56. PubMed ID: 16373187
    [Abstract] [Full Text] [Related]

  • 28. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
    Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP.
    Transfusion; 2004 Jun 01; 44(6):877-85. PubMed ID: 15157255
    [Abstract] [Full Text] [Related]

  • 29. Basics of flow cytometry-based sterility testing of platelet concentrates.
    Mohr H, Lambrecht B, Bayer A, Spengler HP, Nicol SB, Montag T, Müller TH.
    Transfusion; 2006 Jan 01; 46(1):41-9. PubMed ID: 16398729
    [Abstract] [Full Text] [Related]

  • 30. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment.
    Osselaer JC, Messe N, Hervig T, Bueno J, Castro E, Espinosa A, Accorsi P, Junge K, Jacquet M, Flament J, Corash L.
    Transfusion; 2008 Jun 01; 48(6):1061-71. PubMed ID: 18346019
    [Abstract] [Full Text] [Related]

  • 31. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function.
    Singh Y, Sawyer LS, Pinkoski LS, Dupuis KW, Hsu JC, Lin L, Corash L.
    Transfusion; 2006 Jul 01; 46(7):1168-77. PubMed ID: 16836564
    [Abstract] [Full Text] [Related]

  • 32. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R, Fröhlich A, Mayaudon V, Lin L.
    J Clin Apher; 2004 Jul 01; 19(4):185-91. PubMed ID: 15597347
    [Abstract] [Full Text] [Related]

  • 33. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage.
    Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O.
    Transfusion; 2006 May 01; 46(5):800-10. PubMed ID: 16686848
    [Abstract] [Full Text] [Related]

  • 34. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates.
    Mohr H, Bayer A, Gravemann U, Müller TH.
    Transfusion; 2006 Jun 01; 46(6):949-55. PubMed ID: 16734811
    [Abstract] [Full Text] [Related]

  • 35. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
    Osselaer JC, Cazenave JP, Lambermont M, Garraud O, Hidajat M, Barbolla L, Tardivel R, Defoin L, Waller C, Mendel I, Raidot JP, Kandel G, De Meuter R, Fabrigli P, Dehenau D, Arroyo JL, Padrón F, Gouezec H, Corral M, Jacquet M, Sundin D, Lin L, Corash L.
    Vox Sang; 2008 May 01; 94(4):315-23. PubMed ID: 18248574
    [Abstract] [Full Text] [Related]

  • 36. Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry.
    Zavizion B, Serebryanik D, Chapman J, Alford B, Purmal A.
    Vox Sang; 2004 Oct 01; 87(3):143-9. PubMed ID: 15569065
    [Abstract] [Full Text] [Related]

  • 37. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates.
    Terpstra FG, van 't Wout AB, Schuitemaker H, van Engelenburg FA, Dekkers DW, Verhaar R, de Korte D, Verhoeven AJ.
    Transfusion; 2008 Feb 01; 48(2):304-13. PubMed ID: 18028277
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.
    Janetzko K, Cazenave JP, Klüter H, Kientz D, Michel M, Beris P, Lioure B, Hastka J, Marblie S, Mayaudon V, Lin L, Lin JS, Conlan MG, Flament J.
    Transfusion; 2005 Sep 01; 45(9):1443-52. PubMed ID: 16131376
    [Abstract] [Full Text] [Related]

  • 39. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.
    Schlenke P, Hervig T, Isola H, Wiesel ML, Kientz D, Pinkoski L, Singh Y, Lin L, Corash L, Cazenave JP.
    Transfusion; 2008 Apr 01; 48(4):697-705. PubMed ID: 18194378
    [Abstract] [Full Text] [Related]

  • 40. Rapid and sensitive detection of viable bacteria in contaminated platelet concentrates using a newly developed bioimaging system.
    Motoyama Y, Yamaguchi N, Matsumoto M, Kagami N, Tani Y, Satake M, Nasu M.
    Transfusion; 2008 Nov 01; 48(11):2364-9. PubMed ID: 18680549
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.